Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析

◆英語タイトル:Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14783
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus Interlong) is a provider of cytokine protein therapeutic drugs and preventive biological products. The company provides products such as recombinant human interferon a-2b for injection, recombinant human interleukin-2 for injection and subunit influenza vaccine. It conducts research on molecular biology upstream work, protein expression system, prokaryotic, eukaryotic cell culture, and separation and purification of protein drugs and analysis systems. Neptunus Interlong performs preventive vaccine research including traditional vaccine technology improvements, and development of genetically engineered vaccines and DNA vaccines. The company markets its products across China. Neptunus Interlong is headquartered in Shenzhen, China.

Shenzhen Neptunus Interlong Bio-Technique Co Ltd Key Recent Developments

Dec 14,2018: Shenzhen Neptunus Interlong Bio-technique Company receives Research and Development special award fund
Nov 13,2018: Announcements and Notices – ANNOUNCEMENT OF THIRD QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2018
Jul 30,2018: Shenzhen Neptunus Interlong Bio-Tech: Inside information announcement profit warning
Jul 11,2018: Shenzhen Neptunus Interlong Bio-technique: Change of Registered Address

This comprehensive SWOT profile of Shenzhen Neptunus Interlong Bio-Technique Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shenzhen Neptunus Interlong Bio-Technique Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Information
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Overview
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Employees
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Employee Biographies
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Operational Heads
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Major Products and Services
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – History
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Company Statement
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Locations And Subsidiaries
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Business Description
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Corporate Strategy
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Strengths
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Weaknesses
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Opportunities
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Threats
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Information
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Ratios
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Share Data
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Major Products and Services
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, History
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Employees
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Employee Biographies
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Operational Heads
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Other Locations
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Subsidiaries
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Manufacturing facilities
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Competitors
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, SWOT Analysis
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Ratios based on current share price
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Annual Ratios
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Performance Chart
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Ratio Charts

★海外企業調査レポート[Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lepu Medical Technology (Beijing) Co Ltd (300003):医療機器:M&Aディール及び事業提携情報
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company that offers medical equipments, pharmaceutical products and healthcare services. The company’s products include cardiovascular interventional products, surgical cardiology products, peripheral interventio …
  • CDW Corporation:企業の戦略・SWOT・財務情報
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Five Star Senior Living Inc (FVE):企業の財務・戦略的SWOT分析
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Ascential plc:企業の戦略・SWOT・財務情報
    Ascential plc - Strategy, SWOT and Corporate Finance Report Summary Ascential plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Atlas Iron Ltd:企業のM&A・事業提携・投資動向
    Atlas Iron Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atlas Iron Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Fraser & Neave Holdings Bhd:企業の戦略・SWOT・財務情報
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Anheuser-Busch InBev SA/NV:企業の戦略・SWOT・財務分析
    Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report Summary Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析
    Summary Colby Pharmaceutical Company (Colby Pharma) is a biopharma company that focuses on the development of safe and effective small molecule analgesic, anti-inflammatory drug, and immunobiologic products. Its product portfolio includes Oral small molecule analgesics CPC-123 & CPC-111 for post-sur …
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hansen Medical Inc:企業の製品パイプライン分析2018
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Shire Plc (SHP):企業の財務・戦略的SWOT分析
    Shire Plc (SHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Wolverine World Wide, Inc.:企業の戦略・SWOT・財務情報
    Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wolverine World Wide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …
  • Kyowa Hakko Kirin Co., Ltd.:企業の戦略・SWOT・財務情報
    Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Advanced Biological Laboratories SA:医療機器:M&Aディール及び事業提携情報
    Summary Advanced Biological Laboratories SA (ABL) is a medical data technology company that provides integrated software solutions for personalised medicine. The company offers TherapyEdge, a point of care, decision support software for healthcare professionals; and TherapyEdge Box systems, a web ba …
  • OncBioMune Pharmaceuticals Inc (OBMP):製薬・医療:M&Aディール及び事業提携情報
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …
  • Gentiva Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gentiva Health Services Inc (Gentiva), a subsidiary of Kindred Healthcare Inc is a provider of home health and hospice services. It offers various patient care services at the patient’s home or hospital. Its major services include expert nursing care; disease and pain management; medication …
  • Addario Lung Cancer Medical Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Addario Lung Cancer Medical Institute (ALCMI) is a non-profit organization that concentrates on scientific and clinical research and diagnostics for lung cancer. The organization involves in research advancements, invests in discovery of improved treatments and also facilitates early detecti …
  • World Reach Limited (WRR):企業の財務・戦略的SWOT分析
    World Reach Limited (WRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆